"Bright Tongue" and "Wine Glass" signs in amyotrophic lateral sclerosis

João Alfredo M M de Barros1, Arthur Felipe B Vasconcelos2, Ana Luísa C B Gomes2

  • 1Departamento de Medicina Interna, Federal University of Paraíba, João Pessoa, Brazil. jalfredommdb@gmail.com.

Neuroradiology
|January 8, 2026
PubMed

Insights

This case study details a patient with progressive neurological symptoms, ultimately diagnosed with amyotrophic lateral sclerosis (ALS). Classic MRI findings supported the diagnosis of this motor neuron disease.

Area of Science:

  • Neurology
  • Neuroscience
  • Medical Imaging

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
  • Early diagnosis is crucial for patient management and research.
  • Understanding characteristic imaging findings aids in differentiating ALS from other neurological conditions.

Purpose of the Study:

  • To present a case study of amyotrophic lateral sclerosis (ALS).
  • To illustrate classic magnetic resonance imaging (MRI) findings associated with ALS.
  • To emphasize the role of neuroimaging in diagnosing motor neuron diseases.

Main Methods:

  • A detailed clinical case presentation of a 43-year-old male patient.
  • Brain magnetic resonance imaging (MRI) including T2/FLAIR and diffusion-weighted imaging (DWI).
  • Electroneuromyography (EMG) for electrophysiological confirmation.

Main Results:

  • The patient exhibited progressive symptoms including leg monoparesis, spastic dysarthria, tetraparesis, gait disturbance, muscle atrophy, weakness, and fasciculations.
  • Brain MRI revealed characteristic hyperintensities along the corticospinal tracts, including the "bright tongue sign" and "wine glass sign."
  • Electroneuromyography confirmed the diagnosis of amyotrophic lateral sclerosis.

Conclusions:

  • This case demonstrates the typical clinical progression and classic neuroimaging findings of amyotrophic lateral sclerosis (ALS).
  • The "bright tongue sign" and "wine glass sign" on MRI are valuable indicators for ALS diagnosis.
  • Integrated clinical, imaging, and electrophysiological data are essential for accurate diagnosis of ALS.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

6.3K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.6K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
806
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
122.1K
Visual Agnosia01:12

Visual Agnosia

Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
943